{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:37:07Z","timestamp":1767008227917},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1002\/jps.23218","type":"journal-article","created":{"date-parts":[[2012,5,29]],"date-time":"2012-05-29T16:43:54Z","timestamp":1338309834000},"page":"2844-2853","source":"Crossref","is-referenced-by-count":15,"title":["Physicochemical Characterization of a Prodrug of a Radionuclide Decorporation Agent for Oral Delivery"],"prefix":"10.1016","volume":"101","author":[{"given":"Katsuhiko","family":"Sueda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Sadgrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan M.","family":"Fitzsimmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Jay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.23218_bb0010","unstructured":"Package insert. Pentetate calcium trisodium, NDA 021749. Aug. 11, 2004."},{"key":"10.1002\/jps.23218_bb0015","unstructured":"Package insert. Pentetate zinc trisodium, NDA 021751. Aug. 11,2004."},{"key":"10.1002\/jps.23218_bb0020","series-title":"Toxicological profile for americium","author":"Agency for Toxic Substances and Disease Registry","year":"2004"},{"key":"10.1002\/jps.23218_bb0025","series-title":"Toxicological profile for plutonium","author":"Agency for Toxic Substances and Disease Registry","year":"2010"},{"issue":"1","key":"10.1002\/jps.23218_bb0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00004032-198301000-00006","article-title":"The retention of 14C\u2013DTPA in human volunteers after inhalation or intravenous injection","volume":"44","author":"Stather","year":"1983","journal-title":"Health Phys"},{"key":"10.1002\/jps.23218_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0047-0740(79)90061-5","article-title":"The dosimetry of carbon-14 labelled compounds: The metabolism of diethylenetriaminepentaacetic acid (DTPA) in the rat","volume":"6","author":"Crawley","year":"1979","journal-title":"Int J Nucl Med Biol"},{"issue":"1","key":"10.1002\/jps.23218_bb0040","first-page":"27","article-title":"Guidebook for the treatment of accidental internal radionuclide contamination of workers","volume":"41","author":"Gerber","year":"1992","journal-title":"Radiat Prot Dosimetry"},{"issue":"4","key":"10.1002\/jps.23218_bb0045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/HP.0b013e3181c1cccd","article-title":"Structure of a single model to describe plutonium and americium decorporation by DTPA treatments","volume":"99","author":"Fritsch","year":"2010","journal-title":"Health Phys"},{"issue":"3","key":"10.1002\/jps.23218_bb0050","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2307\/3575187","article-title":"Pu and Am decorporation in beagles: Effects of magnitude of initial Ca\u2013DTPA injection upon chelation efficacy","volume":"79","author":"Lloyd","year":"1979","journal-title":"Radiat Res"},{"key":"10.1002\/jps.23218_bb0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1088\/0031-9155\/7\/1\/306","article-title":"The removal of americium and plutonium from the rat by chelating agents","volume":"7","author":"Taylor","year":"1962","journal-title":"Phys Med Biol"},{"key":"10.1002\/jps.23218_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/oxfordjournals.rpd.a032977","article-title":"Optimum treatment regimens with animals","volume":"87","author":"Stradling","year":"2000","journal-title":"Radiat Prot Dosimetry"},{"key":"10.1002\/jps.23218_bb0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2307\/3574740","article-title":"Comparison of the effectiveness of CaDTPA and ZnDTPA in removing 242Cm from the rat","volume":"70","author":"Takada","year":"1977","journal-title":"Radiat Res"},{"key":"10.1002\/jps.23218_bb0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/oxfordjournals.rpd.a080424","article-title":"Lifetime follow-up of the 1976 americium accident victim","volume":"26","author":"Breitenstein","year":"1989","journal-title":"Radiat Pro Dosimetry"},{"key":"10.1002\/jps.23218_bb0075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2307\/3574971","article-title":"Dependency of chelation efficacy upon time after first DTPA injection","volume":"78","author":"Lloyd","year":"1979","journal-title":"Radiat Res"},{"key":"10.1002\/jps.23218_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01213743","article-title":"Effect of drinking Zn\u2013DTPA on 238-Pu and 241-Am in rat bones","volume":"23","author":"Volf","year":"1984","journal-title":"Radiat Environ Biophys"},{"key":"10.1002\/jps.23218_bb0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2174\/1389200033489253","article-title":"Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist","volume":"4","author":"Beaumont","year":"2003","journal-title":"Curr Drug Metab"},{"key":"10.1002\/jps.23218_bb0090","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1021\/jm0303812","article-title":"Lessons learned from marketed and investigational prodrugs","volume":"47","author":"Ettmayer","year":"2004","journal-title":"J Med Chem"},{"issue":"3","key":"10.1002\/jps.23218_bb0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: Design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/jps.23218_bb0100","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jps.2600680219","article-title":"Synthesis and therapeutic testing of mono- and dialkyl esters of pentetic (diethylenetriaminepentaacetic) acid for decorporation of polymeric plutonium","volume":"68","author":"Guilmette","year":"1979","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.23218_bb0105","first-page":"405","article-title":"Removal of polymeric plutonium from mice by combined therapy with the calcium chelate and penta-ethyl ester of DTPA","volume":"7","author":"Markley","year":"1963","journal-title":"Int J Radiat Biol"},{"key":"10.1002\/jps.23218_bb0110","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1021\/jm00079a014","article-title":"Decorporation of aged americium deposits by oral administration of lipophilic polyamino carboxylic acids","volume":"35","author":"Bruenger","year":"1992","journal-title":"J Med Chem"},{"key":"10.1002\/jps.23218_bb0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/HP.0b013e3181bfb99b","article-title":"Pharmacological properties of orally available amphipathic polyaminocarboxylic acid chelators for actinide decorporation","volume":"99","author":"Miller","year":"2010","journal-title":"Health Phys"},{"key":"10.1002\/jps.23218_bb0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.yrtph.2007.12.008","article-title":"Defining maximum levels of higher alcohols in alcoholic beverages and surrogate alcohol products","volume":"50","author":"Lachenmeier","year":"2008","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1002\/jps.23218_bb0125","series-title":"Methods and pharmaceutical compositions for decorporation of radioactive compounds","author":"Jay","year":"2011"},{"key":"10.1002\/jps.23218_bb0130","series-title":"Rockville","author":"United States Pharmacopeia\u2014The National Formulary, USP 34-NF 29","year":"2011"},{"issue":"9","key":"10.1002\/jps.23218_bb0135","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1021\/ac60215a006","article-title":"Nuclear magnetic resonance studies of protonation of polyamine and aminocarboxylate compounds in aqueous solution","volume":"36","author":"Sudmeier","year":"1964","journal-title":"Anal Chem"},{"key":"10.1002\/jps.23218_bb0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mrm.1910080208","article-title":"Stability constants of Gd3+ binding to model DTPA-conjugates and DTPA\u2013proteins: Implications for their use as magnetic resonance contrast agents","volume":"8","author":"Sherry","year":"1988","journal-title":"Magn Reson Med"},{"key":"10.1002\/jps.23218_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1002\/jps.23218_bb0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-409X(96)00425-5","article-title":"Selection of development candidates based on in vitro permeability measurements","volume":"23","author":"Lee","year":"1997","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1002\/jps.23218_bb0155","unstructured":"ChemBioDraw Ultra 11.0.1. Cambridge,Massachusetts: CambridgeSoft."},{"key":"10.1002\/jps.23218_bb0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-199936030-00004","article-title":"Drug, meal and formulation interactions influencing drug absorption after oral administration","volume":"36","author":"Fleisher","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.23218_bb0165","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/204580a0","article-title":"Esterase activity of pepsin","volume":"204","author":"Lokshina","year":"1964","journal-title":"Nature"},{"key":"10.1002\/jps.23218_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0169-409X(96)00489-9","article-title":"Influence of lipolysis on drug absorption from the gastro-intestinal tract","volume":"25","author":"MacGregor","year":"1997","journal-title":"Adv Drug Delivery Rev"},{"issue":"1","key":"10.1002\/jps.23218_bb0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1517\/17425247.3.1.97","article-title":"Development of supersaturable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs","volume":"3","author":"Gao","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1002\/jps.23218_bb0180","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/jps.23218_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jconrel.2005.09.029","article-title":"Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation","volume":"110","author":"Phan","year":"2005","journal-title":"J Control Release"},{"issue":"2","key":"10.1002\/jps.23218_bb0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09553008814550611","article-title":"Reducing the radiation dose from inhaled americium-241 using continuously administered DTPA therapy","volume":"53","author":"Guilmette","year":"1988","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"10.1002\/jps.23218_bb0195","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/09553008914551641","article-title":"The efficacies of pure LICAM(C) and DTPA on the retention of plutonium-238 and americium-241 in rats after their inhalation as nitrates and intravenous injection as citrate","volume":"56","author":"Stradling","year":"1989","journal-title":"Int J Radiat Biol"},{"issue":"1\u20134","key":"10.1002\/jps.23218_bb0200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/oxfordjournals.rpd.a006225","article-title":"Scientific basis for the development of biokinetic models for radionuclide-contaminated wounds","volume":"105","author":"Guilmette","year":"2003","journal-title":"Radiat Prot Dosimetry"},{"key":"10.1002\/jps.23218_bb0205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"issue":"6","key":"10.1002\/jps.23218_bb0210","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jps.20542","article-title":"Enzymes involved in the bioconversion of ester-based prodrugs","volume":"95","author":"Liederer","year":"2006","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1002\/jps.23218_bb0215","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2133\/dmpk.21.173","article-title":"Human carboxylesterase isozymes: Catalytic properties and rational drug design","volume":"21","author":"Imai","year":"2006","journal-title":"Drug Metab Pharmacokinet"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915314969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915314969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T23:25:48Z","timestamp":1542929148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915314969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0022354915314969"],"URL":"https:\/\/doi.org\/10.1002\/jps.23218","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}